Dipal Doshi, Entrada CEO

IPO flood­gates open up af­ter sum­mer lull as five more biotechs file for Nas­daq

It’s once again open sea­son for biotech IPOs, as the sum­mer drought has giv­en way to an au­tumn flood.

Five com­pa­nies filed to go pub­lic on Fri­day, in­clud­ing four pen­cil­ing in $100 mil­lion fundrais­es: Evotec, En­tra­da Ther­a­peu­tics, Au­ra Bio­sciences and Vaxxin­i­ty. The fifth biotech, Blue Wa­ter Vac­cines, is es­ti­mat­ing a more mod­est $24 mil­lion.

The com­bined in­dus­try raise sur­passed $14 bil­lion last week af­ter two more biotechs priced, per the End­points News tal­ly, and the sec­tor re­mains on pace to eclipse last year’s record of $16.5 bil­lion. It could come down to the wire, how­ev­er, af­ter a third quar­ter lull that saw the low­est lev­els of IPO num­bers since the start of 2020.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.